Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    1665400 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Qidong Hepatitis B Intervention Study
Conditions: Hepatitis B;   Liver Neoplasms;   Liver Diseases
Intervention: Biological: Hep-V Vax

Indicates status has not been verified in more than two years